Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Obese women with PCOS are more likely to have fatty liver disease.

Finasteride improves acne and hair loss in women with normal testosterone.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Prolactin may be important for skin growth and immune function.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.